Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 349807, 11 pages
http://dx.doi.org/10.1155/2011/349807
Research Article

Administration of a Decoction of Sucrose- and Polysaccharide-Rich Radix Astragali (Huang Qi) Ameliorated Insulin Resistance and Fatty Liver but Affected Beta-Cell Function in Type 2 Diabetic Rats

1Institute of Pharmacology, Yang Ming University, Taipei 112, Taiwan
2Division of Herbal Drugs and Natural Products, National Research Institute of Chinese Medicine, Taipei 112, Taiwan
3Division of Medicinal Chemistry, National Research Institute of Chinese Medicine, Taipei 112, Taiwan

Received 2 November 2010; Accepted 16 December 2010

Copyright © 2011 Yi-Chen Juan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Mudaliar and R. R. Henry, “Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial function,” American Journal of Medicine, vol. 123, no. 3, pp. S19–S27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Cusi, “Nonalcoholic fatty liver disease in type 2 diabetes mellitus,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 16, no. 2, pp. 141–149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Q. Ma, Q. Shi, J. A. Duan, T. T. X. Dong, and K. W. K. Tsim, “Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations,” Journal of Agricultural and Food Chemistry, vol. 50, no. 17, pp. 4861–4866, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Chen, Y. M. Li, and M. H. Yu, “Astragalus polysaccharides: an effective treatment for diabetes prevention in NOD mice,” Experimental and Clinical Endocrinology and Diabetes, vol. 116, no. 8, pp. 468–474, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Li, S. D. Qiu, H. X. Chen, H. Tian, and H. X. Wang, “The immunotherapeutic effects of Astragalus polysaccharide in type 1 diabetic mice,” Biological and Pharmaceutical Bulletin, vol. 30, no. 3, pp. 470–476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Liu, K. Wu, X. Mao, Y. Wu, and J. Ouyang, “Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle,” Journal of Ethnopharmacology, vol. 127, no. 1, pp. 32–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Wang, D. Zhang, X. Mao, F. Zou, H. Jin, and J. Ouyang, “Astragalus polysaccharides decreased the expression of PTP1B through relieving ER stress induced activation of ATF6 in a rat model of type 2 diabetes,” Molecular and Cellular Endocrinology, vol. 307, no. 1-2, pp. 89–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Chen, Y. M. Li, and M. H. Yu, “Astragalus polysaccharides inhibited diabetic cardiomyopathy in hamsters depending on suppression of heart chymase activation,” Journal of Diabetes and Its Complications, vol. 24, no. 3, pp. 199–208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. W. Zhang, C. Y. Wu, and J. T. Cheng, “Merit of Astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expressions of NF-κB and IκB in renal cortex of streptozotoxin-induced diabetic rats,” Journal of Ethnopharmacology, vol. 114, no. 3, pp. 387–392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Q. Mao, Y. Wu, KE. Wu et al., “Astragalus polysaccharide reduces hepatic endoplasmic reticulum stress and restores glucose homeostasis in a diabetic KKAy mouse model,” Acta Pharmacologica Sinica, vol. 28, no. 12, pp. 1947–1956, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. H. J. Kwon, Y. Y. Kim, and S. Y. Choung, “Amelioration effects of traditional Chinese medicine on alcohol-induced fatty liver,” World Journal of Gastroenterology, vol. 11, no. 35, pp. 5512–5516, 2005. View at Google Scholar · View at Scopus
  12. X. Yin, Y. Zhang, J. Yu et al., “The antioxidative effects of Astragalus saponin I protect against development of early diabetic nephropathy,” Journal of Pharmacological Sciences, vol. 101, no. 2, pp. 166–173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Motomura, Y. Fujiwara, N. Kiyota et al., “Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products,” Journal of Agricultural and Food Chemistry, vol. 57, no. 17, pp. 7666–7672, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. C. Juan, W. J. Tsai, Y. L. Lin et al., “The novel anti-hyperglycemic effect of Paeoniae radix via the transcriptional suppression of phosphoenopyruvate carboxykinase (PEPCK),” Phytomedicine, vol. 17, no. 8-9, pp. 626–634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. C. C. Chen, C. Y. Hsu, C. Y. Chen, and H. K. Liu, “Fructus Corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death,” Journal of Ethnopharmacology, vol. 117, no. 3, pp. 483–490, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. F. M. Liu, Z. X. Li, Y. F. Meng, and Y. Z. Chen, “Studies on isolation, purification and structure of polysaccharide RHG from Hedysarum polybotrys hand.-mazz,” Acta Pharmaceutica Sinica, vol. 32, no. 8, pp. 603–606, 1997. View at Google Scholar · View at Scopus
  18. CCMP, “Information center for the safty of the employment of Chinese herbal medicine: Radix Astragali,” 2004, http://tcam.ccmp.gov.tw/meun_1_content.asp?aaa=20.
  19. M. S. Wang, J. Li, H. X. Di et al., “Clinical study on effect of Astragalus injection and its immuno-regulation action in treating chronic aplastic anemia,” Chinese Journal of Integrative Medicine, vol. 13, no. 2, pp. 98–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. L. Zhou, P. Yu, and D. Lin, “Study on effect of Astragalus injection in treating congestive heart failure,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 21, no. 10, pp. 747–749, 2001. View at Google Scholar · View at Scopus
  21. H. Huang, “The diuretic and the blood pressure lowering effects of Radix Astragali,” Journal of Pharmacology, vol. 12, p. 319, 1965. View at Google Scholar
  22. Y. Zhang, Y. Wang, and C. Sheng, “The anti-inflammatory and the hypotensive effects of Astragaloside I,” Journal of Pharmacology, vol. 19, no. 5, p. 333, 1984. View at Google Scholar
  23. F. Zou, X. Q. Mao, N. Wang, J. Liu, and J. P. Ou-Yang, “Astragalus polysaccharides alleviates glucose toxicity and restores glucose homeostasis in diabetic states via activation of AMPK,” Acta Pharmacologica Sinica, vol. 30, no. 12, pp. 1607–1615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Ferré and F. Foufelle, “SREBP-1c transcription factor and lipid homeostasis: clinical perspective,” Hormone Research, vol. 68, no. 2, pp. 72–82, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. H. J. Harwood Jr., “Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome,” Current Opinion in Investigational Drugs, vol. 5, no. 3, pp. 283–289, 2004. View at Google Scholar · View at Scopus
  26. R. J. Li, S. D. Qiu, H. X. Chen, H. Tian, and G. Q. Liu, “Effect of Astragalus polysaccharide on pancreatic cell mass in type 1 diabetic mice,” Zhongguo Zhongyao Zazhi, vol. 32, no. 20, pp. 2169–2173, 2007. View at Google Scholar · View at Scopus
  27. K. L. Stanhope and P. J. Havel, “Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup,” American Journal of Clinical Nutrition, vol. 88, no. 6, pp. 1733S–1737S, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. S. Elliott, N. L. Keim, J. S. Stern, K. Teff, and P. J. Havel, “Fructose, weight gain, and the insulin resistance syndrome,” American Journal of Clinical Nutrition, vol. 76, no. 5, pp. 911–922, 2002. View at Google Scholar · View at Scopus
  29. B. Maiztegui, M. I. Morelli, M. A. Raschia, H. Del Zotto, and J. J. Gagliardino, “Islet adaptive changes to fructose-induced insulin resistance: β-cell mass, glucokinase, glucose metabolism, and insulin secretion,” Journal of Endocrinology, vol. 200, no. 2, pp. 139–149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. T. M. Chien, “Analysis of crude drug preparations used in Traditional Chinese Medicine in Taiwan National Health Insurance (2002-2003),” Chinese Medical University, 2006.
  31. W. Jia, W. Gao, and L. Tang, “Antidiabetic herbal drugs officially approved in China,” Phytotherapy Research, vol. 17, no. 10, pp. 1127–1134, 2003. View at Publisher · View at Google Scholar · View at Scopus